Live Breaking News & Updates on Stereotypic Movement Disorder

New Drug Discovered to Treat Intellectual Disabilities
by Pooja Shete on 
December 17, 2020 at 12:58 PM
Fragile X Syndrome is a genetic disorder which cause mild to moderate intellectual disability. It is one of the leading causes of autism. A new drug has been discovered which is the first drug for the treatment for Fragile X Syndrome.
The research was conducted as collaboration between University at Buffalo and Tetra Therapeutics.
The drug BPN14770 showed positive results in phase 2 clinical study and improved cognitive function in adult male patients with Fragile X Syndrome.
According to the Centers for Disease Control and Prevention,
Fragile X Syndrome is the most common cause of inherited intellectual disability and there is no cure for it. ....

Elizabeth Berry Kravis , Mark Gurney , Jamesm Odonnell , Ying Xu , Centers For Disease , Rush University Medical Center , Ub School Of Pharmacy , Stereotypic Movement Disorder , Research Foundation , University At Buffalo , Fragilex Syndrome , Disease Control , Tetra Therapeutics , Rush University Medical , Pharmaceutical Sciences , With Fragilex Syndrome Have , Bias Toward Threatening , Improve Eye Gaze Behavior , Movement Disorder , Toxicityclinical Trials , Signature Drug Toxicitydrugs Banned , எலிசபெத் பெர்ரி கிராவிஸ் , குறி கர்னி , யிங் ஐயூ , மையங்கள் க்கு நோய் , அவசரம் பல்கலைக்கழகம் மருத்துவ மையம் ,